Thomas Tu - Oct 27, 2021 Form 4 Insider Report for Inari Medical, Inc. (NARI)

Role
Chief Medical Officer
Signature
/s/ Angela Ahmad, attorney-in-fact for Thomas Tu
Stock symbol
NARI
Transactions as of
Oct 27, 2021
Transactions value $
-$436,091
Form type
4
Date filed
10/28/2021, 09:43 PM
Previous filing
Oct 4, 2021
Next filing
Nov 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Options Exercise $2.29K +5K +10.29% $0.46* 53.6K Oct 27, 2021 Direct
transaction NARI Common Stock Sale -$378K -4.32K -8.06% $87.55 49.3K Oct 27, 2021 Direct F1, F2
transaction NARI Common Stock Sale -$60.1K -680 -1.38% $88.44 48.6K Oct 27, 2021 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NARI Stock Option Options Exercise $0 -5K -2.27% $0.00 216K Oct 27, 2021 Common Stock 5K $0.46 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2020.
F2 This transaction was executed in multiple trades at prices ranging from $87.12 to $88.03 The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $88.20 to $88.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 Option vested with respected with 25% of the underline shares on April 30, 2020 and vest with respect to the remaining shares in 36 equal monthly installment there after.